CSGP vs PPCB · P/E 484, rev $2.74B vs P/E 0.0, $3.9M cap
CoStar Group Inc (CSGP) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
PPCB does not have a complete income-statement cache yet.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CSGP and PPCB stock pages for the full models.
Not investment advice.